Compound ID | 1373
Class: Cyclin dependant kinase-2 inhibitor/ ATR inhibitor
| Details of activity: | Has been shown to be an effective inhibitor of Mycobacterium tuberculosis |
| Institute where first reported: | Cayman Chemical |
| Year first mentioned: | 2011 |
| Highest developmental phase: | Preclinical |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/398148 |
| Citations: |
|